RG-12986

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRG-12986
Drug Alias NameRG12986RG 12986RG-12986
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant coagulation factor
Mechanisms of ActionGlycoprotein Ib platelet beta subunit antagonistsPlatelet aggregation inhibitors
TargetsGlycoprotein Ib platelet beta subunit
Therapy Area/IndicationsThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAventisSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofiAventis
Active IndicationsN/A
Inactive IndicationsThrombosis

Other Information

ATC CodeN/A
Related LinksN/A